Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Dechra Pharmaceuticals PLC

Dechra is a global specialist in veterinary pharmaceuticals and related products business, engaged in the development, manufacture, marketing, and sales of high-quality products exclusively for veterinarians worldwide.

msh id	COM:DECHRA
symbol	DPH
name	Dechra Pharmaceuticals PLC
homepage url	https://www.dechra.com
country	GB
sector	Healthcare
industry	Drug Manufacturers - General
market	STOCKS
employee count	2.46K
crunchbase url	-
linkedin url	-
founders	-

market cap	57.06M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.48
growth cost of revenue	0.13
growth depreciation and amortization	0.01
growth ebitda	-0.61
growth ebitda ratio	-0.65
growth eps	-
growth eps diluted	-
growth general and administrative expenses	1.01
growth gross profit	0.11
growth gross profit ratio	-0.01

COM:DECHRA

Dechra

Last Close

3,864.00

15/01 17:38

Market Cap

44.04M

Beta: -

Volume Today

192.11K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	947.99M
cost of revenue	947.99M
depreciation and amortization	112.6M
ebitda	123.14M
ebitda ratio	0.13
eps	-0.31
eps diluted	-0.3
operating expenses	527.22M
operating income	7.91M
operating income ratio	0.01

accounts receivables	-26.99M
capital expenditure	-38.03M
cash at beginning of period	151.76M
cash at end of period	93.39M
inventory	272.77M
working capital ttm	303.9M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-